A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00674310

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:41.548086+00:00

Published At

2018-01-23T00:00:00+00:00

Record Updated At

2018-01-23

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Parkinson\u0027s Disease", "Restless Leg Syndrome"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-01-23"

protocolSection.identificationModule.nctId

"NCT00674310"

protocolSection.identificationModule.officialTitle

"A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Parkinson's Disease (protocolSection.conditionsModule.conditions)
• Restless Leg Syndrome (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.